Johns Hopkins Medicine International, LLC, headquartered in the United States, is a leading entity in the global healthcare industry, specialising in medical education, clinical services, and health system consulting. Founded as part of the renowned Johns Hopkins Medicine in 1996, the organisation has established a strong presence in key operational regions, including Asia, the Middle East, and Europe. With a commitment to excellence, Johns Hopkins Medicine International offers a range of unique services, including telemedicine, training programmes, and access to world-class specialists. The organisation is recognised for its innovative approaches to healthcare delivery and has achieved notable milestones, such as partnerships with various international health institutions. As a trusted name in global health, it continues to enhance patient care and medical education worldwide.
How does Johns Hopkins Medicine International, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Johns Hopkins Medicine International, LLC's score of 20 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Johns Hopkins Medicine International, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The organisation is a current subsidiary of Johns Hopkins University, which may influence its climate commitments and initiatives. While there are no documented reduction targets or climate pledges from Johns Hopkins Medicine International, LLC, it is important to note that emissions data and climate strategies may be inherited from its parent organisation. As a subsidiary, it may align with broader sustainability goals set by Johns Hopkins University, although specific details on these initiatives are not provided. In the context of the healthcare industry, organisations are increasingly recognising the importance of addressing climate change and reducing carbon footprints. However, without specific emissions data or reduction targets, it is challenging to assess the current climate commitments of Johns Hopkins Medicine International, LLC.
Access structured emissions data, company-specific emission factors, and source documents
| 2008 | 2017 | 2019 | 2022 | |
|---|---|---|---|---|
| Scope 1 | - | 0,000,000,000 | - | 00,000,000 |
| Scope 2 | - | 0,000,000,000 | - | 00,000,000 |
| Scope 3 | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Johns Hopkins Medicine International, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.